生物仿制药药物警戒和风险管理

评论文章

Biosimilars: Regulatory Status and Implications across the World

  • Rajesh Kumar, Sandra Sigala, Renato Bertini Malgarini, Giuseppe Pimpinella, Luca Pani, Sergio Pecorelli and Maurizio Memo

评论文章

Pharmacovigilance of Oncology Biosimilars

  • Luis H. Camacho and Nikhil Pai